Open Interest and Volume Dynamics
On 24 June 2026, Lupin Ltd. recorded an open interest of 30,129 contracts in its derivatives, marking a substantial increase of 3,578 contracts or 13.48% compared to the previous OI of 26,551. This rise in open interest was accompanied by a trading volume of 32,367 contracts, indicating robust participation in the futures and options market. The futures segment alone accounted for a value of approximately ₹79,211.92 lakhs, while the options segment’s notional value stood at an impressive ₹25,267.60 crores, culminating in a total derivatives value of ₹81,780.30 lakhs.
The increase in open interest alongside rising volume typically reflects fresh capital entering the market, suggesting that traders are establishing new positions rather than merely closing existing ones. This pattern often precedes significant price movements, as it indicates a build-up of market conviction.
Price Performance and Technical Indicators
Lupin’s underlying share price closed at ₹2,377, just 4.93% shy of its 52-week high of ₹2,494. The stock has outperformed its sector by 0.52% on the day, delivering a 0.78% gain compared to the sector’s 0.30% and the Sensex’s 1.02% returns. Notably, Lupin has recorded gains over the last two consecutive trading sessions, accumulating a 1.58% return during this period.
From a technical standpoint, Lupin is trading above all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — signalling a strong upward momentum. This alignment of moving averages often attracts momentum traders and institutional investors, reinforcing bullish sentiment.
Investor Participation and Liquidity
Investor participation has also shown signs of strengthening. Delivery volume on 23 June reached 4.34 lakh shares, a 2.4% increase over the five-day average delivery volume, indicating that more investors are holding shares rather than trading intraday. This rising delivery volume is a positive sign of conviction among long-term investors.
Liquidity remains adequate for sizeable trades, with the stock’s average traded value supporting trade sizes up to ₹4.16 crores based on 2% of the five-day average traded value. This level of liquidity ensures that institutional investors can enter or exit positions without significant price impact, further supporting the stock’s attractiveness.
Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!
- - Rigorous evaluation cleared
- - Expert-backed selection
- - Mid Cap conviction pick
Market Positioning and Directional Bets
The surge in open interest, coupled with rising volumes and price appreciation, suggests that market participants are positioning for a potential upward move in Lupin’s stock. The increase in futures open interest by 13.48% indicates that traders are likely taking fresh long positions, anticipating further gains.
Options market data, with a notional value exceeding ₹25,267 crores, points to significant hedging and speculative activity. The high options value relative to futures suggests that investors are actively managing risk while positioning for directional moves. This could imply a balanced approach where participants are optimistic but remain cautious given the sector’s inherent volatility.
Lupin’s Mojo Score currently stands at 77.0 with a Mojo Grade of Buy, recently downgraded from a Strong Buy on 25 May 2026. This adjustment reflects a slight moderation in analyst enthusiasm but still indicates a favourable outlook. The mid-cap pharmaceutical company’s market capitalisation is ₹1,08,652.17 crores, placing it solidly within the mid-cap segment, which often attracts investors seeking growth with manageable risk.
Sector and Benchmark Comparison
Within the Pharmaceuticals & Biotechnology sector, Lupin’s recent outperformance relative to the sector average and the broader Sensex index highlights its relative strength. The sector’s 1-day return of 0.30% pales in comparison to Lupin’s 0.78%, underscoring the stock’s appeal amid sectoral headwinds or consolidation phases.
Moreover, Lupin’s proximity to its 52-week high suggests that the stock is nearing a critical resistance level. Should the stock break above this threshold, it could trigger further buying interest and potentially attract momentum-driven funds.
Want to dive deeper on Lupin Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook and Investor Considerations
While the recent surge in open interest and volume signals bullish sentiment, investors should remain mindful of the broader market environment and sector-specific risks. The pharmaceutical industry is subject to regulatory changes, patent expiries, and competitive pressures that can impact earnings and valuations.
However, Lupin’s strong technical positioning, rising investor participation, and solid fundamentals as reflected in its Mojo Grade Buy rating provide a compelling case for continued interest. The stock’s ability to sustain above key moving averages and approach its 52-week high suggests that upward momentum could persist in the near term.
Investors looking to capitalise on this trend should monitor open interest and volume patterns closely, as any sudden reversal or decline in these metrics could signal a shift in market sentiment. Additionally, keeping an eye on sector developments and Lupin’s quarterly earnings will be crucial to validate the current bullish stance.
Summary
Lupin Ltd.’s derivatives market activity reveals a clear increase in open interest and volume, reflecting heightened investor engagement and a probable directional bet favouring price appreciation. Supported by strong technical indicators and a solid fundamental rating, the stock appears well-positioned for further gains, albeit with the usual caution warranted in the pharmaceutical sector.
Market participants should weigh these factors carefully, balancing the promising momentum against sectoral uncertainties to make informed investment decisions.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
